ArticleBlood2008

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy.

Ping Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.